BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25830567)

  • 1. Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling.
    Hou J; Wang Z; Xu H; Yang L; Yu X; Yang Z; Deng Y; Meng J; Feng Y; Guo X; Yang G
    PLoS One; 2015; 10(4):e0122179. PubMed ID: 25830567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.
    Law AY; Wong CK
    Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
    Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
    Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro.
    Raulic S; Ramos-Valdes Y; DiMattia GE
    J Endocrinol; 2008 Jun; 197(3):517-29. PubMed ID: 18492817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression.
    Na SS; Aldonza MB; Sung HJ; Kim YI; Son YS; Cho S; Cho JY
    Biochim Biophys Acta; 2015 Jun; 1854(6):668-76. PubMed ID: 25463045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling.
    Yang S; Ji Q; Chang B; Wang Y; Zhu Y; Li D; Huang C; Wang Y; Sun G; Zhang L; Guan Q; Xiang J; Wei W; Lu Z; Liao T; Meng J; Wang Z; Ma B; Zhou L; Wang Y; Yang G
    Oncotarget; 2017 Jan; 8(4):5976-5991. PubMed ID: 27863406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.
    Zwanziger D; Badziong J; Ting S; Moeller LC; Schmid KW; Siebolts U; Wickenhauser C; Dralle H; Fuehrer D
    Endocr Relat Cancer; 2015 Oct; 22(5):819-30. PubMed ID: 26219679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin-4 controls the proliferation, apoptosis, migration and in vivo growth of MCF-7 breast cancer cells.
    Ma X; Miao H; Jing B; Pan Q; Zhang H; Chen Y; Zhang D; Liang Z; Wen Z; Li M
    Oncol Rep; 2015 Aug; 34(2):681-90. PubMed ID: 26058359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma.
    Volland S; Kugler W; Schweigerer L; Wilting J; Becker J
    Int J Cancer; 2009 Nov; 125(9):2049-57. PubMed ID: 19582875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.
    Lin C; Sun L; Huang S; Weng X; Wu Z
    Biomed Res Int; 2019; 2019():8042489. PubMed ID: 32258098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stanniocalcin 2 promotes cell proliferation and cisplatin resistance in cervical cancer.
    Wang Y; Gao Y; Cheng H; Yang G; Tan W
    Biochem Biophys Res Commun; 2015 Oct; 466(3):362-8. PubMed ID: 26361149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia.
    Law AY; Wong CK
    Exp Cell Res; 2010 Feb; 316(3):466-76. PubMed ID: 19786016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effects of stanniocalcin-related polypeptides on macrophage foam cell formation and vascular smooth muscle cell migration.
    Yamamoto K; Tajima Y; Hasegawa A; Takahashi Y; Kojima M; Watanabe R; Sato K; Shichiri M; Watanabe T
    Peptides; 2016 Aug; 82():120-127. PubMed ID: 27346255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stanniocalcin 2 contributes to aggressiveness and is a prognostic marker for oral squamous cell carcinoma.
    Ferreira do Carmo A; Dourado MR; Ervolino de Oliveira C; Bastos DC; Domingueti CB; Ribeiro Paranaíba LM; Sawazaki-Calone Í; Borges GÁ; Silva Guerra EN; Casarin RC; Graner E; Salo TA; de Almeida Freitas R; Galvão HC; Coletta RD
    Exp Cell Res; 2020 Aug; 393(2):112092. PubMed ID: 32445747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.